- 专利标题: Vaccination with immuno-isolated cells producing an immunomodulator
-
申请号: US15332375申请日: 2016-10-24
-
公开(公告)号: US09861689B2公开(公告)日: 2018-01-09
- 发明人: Nicolas Mach
- 申请人: MaxiVAX SA
- 申请人地址: CH Geneva
- 专利权人: MaxiVax SA
- 当前专利权人: MaxiVax SA
- 当前专利权人地址: CH Geneva
- 代理机构: Cooley LLP
- 代理商 Ivor R. Elrifi; Christina K. Stock
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61K9/00 ; C12P21/00 ; A61K9/48
摘要:
Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as GM-CSF (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic or preventative vaccination against tumors or infectious agents.
公开/授权文献
信息查询